继发性痴呆机制与干预策略的演变回顾
A Review of the Evolution of Secondary Dementia Mechanism and Intervention Strategies
DOI: 10.12677/IJPN.2017.63003, PDF, HTML, XML, 下载: 1,553  浏览: 3,314  国家自然科学基金支持
作者: 刘 琳, 李佳丽, 周 游, 王冬雪, 赵 瑛*：哈尔滨商业大学药学院，黑龙江 哈尔滨
关键词: 继发性痴呆；发病机制；诊断标准；干预策略；Secondary Dementia； Pathogenesis； Diagnostic Criteria； Intervention Strategy
摘要: 继发性痴呆是指在只能已获得相当发展之后，由于疾病引起的继发性的智能减退。人们对继发性痴呆的认识在不断深化，诊断标准日益严格，干预机制趋于多样，干预重点从治疗转为预防。本文综述了从上个世纪80年代到现在，人们对继发性痴呆的发病机制、诊断标准和干预手段上的变化，为人们分析疾病，认识疾病，控制疾病的发展提供了理论参考依据。
Abstract: Secondary dementia refers to the secondary development of secondary dementia after the development of secondary dementia. People continue to deepen the understanding of secondary dementia. The increasing diagnostic criteria are becoming stricter, and the intervention mechanism tends to be diverse. Intervention focus shifts from treatment to prevention. This paper reviews the changes in the pathogenesis, diagnostic criteria and intervention methods of secondary dementia from the 1980s to the present, and provides a theoretical basis for analyzing the disease, understanding the disease and controlling the development of the disease.
文章引用：刘琳, 李佳丽, 周游, 王冬雪, 赵瑛. 继发性痴呆机制与干预策略的演变回顾[J]. 国际神经精神科学杂志, 2017, 6(3): 13-17. https://doi.org/10.12677/IJPN.2017.63003

参考文献

[1] 王拥军. 神经病学[M]. 北京: 科学出版社, 2009: 100-110.
[2] Wu, Y.T., Fratiglioni, L., Matthews, F.E., et al. (2015) Dementia in Western Europe: Epidemiological Evidence and Implications for Policy Making. The Lancet Neurology, 20, S1474-S4422.
[3] Ojo, O. and Brooke, J. (2015) Evaluating the Association between Diabetes, Cognitive Decline and Dementia. International Journal of Environmental Research and Public Health, 12, 8281-8294.
https://doi.org/10.3390/ijerph120708281
[4] Watkins, C.C. and Treisman, G.J. (2015) Cognitive Impairment in Patients with AIDS-Prevalence and Severity. HIV AIDS, 7, 35-47.
https://doi.org/10.2147/HIV.S39665
[5] Wesseling, J.F. and Pérez-Otaño, I. (2015) Modulation of GluN3A Expression in Huntington Disease: A New N-methyl-D-aspartate Receptor-Based Therapeutic Approach? JAMA Neurology, 72, 468-473.
https://doi.org/10.1001/jamaneurol.2014.3953
[6] 周炯, 王百辰. 血管性认知功能损害及血管性痴呆的现代诊断标准[C]//天坛国际脑血管病会议. 2013: 389-393.
[7] 蒋长好, 陈婷婷. 有氧锻炼对执行控制和脑功能的影响[J]. 心理科学进展, 2013, 21(10): 1844-1850.
[8] Ahmed, R.M., Latheef, S., Bartley, L., et al. (2015) Eating Behavior in Frontotemporal Dementia: Peripheralhormones vs. Hypothalamic Pathology. Neurology, 85, 1310-1317.
https://doi.org/10.1212/WNL.0000000000002018
[9] Jensen, C.S., Hasselbalch, S.G., Waldemar, G., et al. (2015) Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives. Frontiers in Neurology, 6, 187.
https://doi.org/10.3389/fneur.2015.00187
[10] Dregan, A., Chowienczyk, P. and Gulliford, M.C. (2015) Are Inflammation and Related Therapy Associated with All-Cause Dementia in a Primary Care Population? Journal of Alzheimer’s Disease, 46, 1039-1047.
https://doi.org/10.3233/JAD-150171
[11] 陈建平, 饶冬萍, 黄若燕. 非典型抗精神病药治疗痴呆的精神行为症状的疗效[J]. 实用医学杂志, 2016, 10: 1690-1692.
[12] Maxwell, C.J., Stock, K., Seitz, D., et al. (2014) Persistence and Adherence with Dementia Pharmacotherapy: Relevance of Patient, Provider, and System Factors. The Canadian Journal of Psychiatry, 59, 624-631.
https://doi.org/10.1177/070674371405901203
[13] Azermai, M. (2015) Dealing with Behavioral and Psychological Symptoms of Dementia: A General Overview. Psychology Research and Behavior Management, 8, 181-185.
https://doi.org/10.2147/PRBM.S44775
[14] Ritchie, K. and Touchon, J. (2000) Mild Cognitive Impairment: Conceptual Basis and Current Nosological Status. The Lancet, 355, 225-228.
[15] Petersen, R.C., Smith, G.E., Waring, S.C., et al. (1999) Mild Cognitive Impairment: Clinical Characterization and Outcome. Archives of Neurology, 56, 303-308.
https://doi.org/10.1001/archneur.56.3.303
[16] 田金洲, 时晶, 张新卿, 等. 轻度认知损害临床研究指导原则(草案)[J]. 中西医结合学报, 2008, 6(1): 9-14.
[17] Ihara, M. and Kalaria, R.N. (2014) Understanding and Preventing the Development of Post-Stroke Dementia. Expert Review of Neurotherapeutics, 14, 1067-1077.
https://doi.org/10.1586/14737175.2014.947276
[18] Li, J., Shao, Y.H., Gong, Y.P., et al. (2014) Diabetes Mellitus and Dementia—A Systematic Review and Meta-Analysis. European Review for Medical and Pharmacological Sciences, 18, 1778-1789.
[19] Baskys, A. (2014) Integration of Genomic Information in Development of Pharmacological Vascular Dementia Prevention and Treatment Strategies. Journal of Alzheimer’s Disease, No. 3, S267-S276.
[20] Eckel, R.H., Jakicic, J.M., Ard, J.D., et al. (2013) AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63, 2960-2984.
[21] Schwartz, J.B. (2015) Primary Prevention: Do the Very Elderly Require a Different Approach? Trends in Cardiovascular Medicine, 25, 228-239.
[22] Stella, F., Radanovic, M., Canineu, P.R., et al. (2015) Anti-Dementia Medications: Current Prescriptions in Clinical Practice and New Agents in Progress. Therapeutic Advances in Drug Safety, 6, 151-165.
https://doi.org/10.1177/2042098615592116